Intelligence · Clinical Development
Pipeline search results
Programs matching “Gilead Sciences” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 56 pipeline programs matching "Gilead Sciences" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
GS-2829
Gilead Sciences Ireland UC
Chronic Hepatitis B
1 trial -
GS-5245 tablets 175 mg, GS-5245 tablets 350 mg
Gilead Sciences Pty Limited
Renal Impairment
1 trial -
Lanraplenib.
Gilead Sciences Ireland UC
Inflammatory Disease
1 trial -
SOF/VEL/VOX
Gilead Sciences Ireland UC
HCV Infection
1 trial -
Study of GS-0151 in Participants With Rheumatoid Arthritis
Gilead Sciences Pty Limited
Rheumatoid Arthritis
1 trial -
Study of GS-5319 in Adults With Solid Tumors
Gilead Sciences Pty Limited
Advanced solid tumors
1 trial -
Biktarvy 50 mg/200 mg/25 mg film-coated tablets
Gilead Sciences Pty Limited
HIV-1 infection
1 trial -
TDF
Gilead Sciences Ireland UC
Chronic Hepatitis B
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.